Enhabit, Inc.

Equities

EHAB

US29332G1022

Healthcare Facilities & Services

Real-time Estimate Cboe BZX Other stock markets 12:31:10 2024-05-03 pm EDT			5-day change	1st Jan Change
10.24 ^USD	+2.55%		+1.99%	-1.16%

Mar. 08	UBS Adjusts Enhabit Price Target to $10 From $9.50, Maintains Neutral Rating	MT
Mar. 08	North American Morning Briefing : Stock Futures -2-	DJ

AREX Capital Issues Letter to Board of Directors of Enhabit, Inc

June 13, 2023 at 01:28 pm EDT

On June 13, 2023, AREX Capital Management, announced that it has issued an open letter to Enhabit, Inc's Board of Directors, outlines the concerns with the Company's poor share price performance and seeks commitment to launch review of strategic alternatives before the end of 2023.

Latest news about Enhabit, Inc.

UBS Adjusts Enhabit Price Target to $10 From $9.50, Maintains Neutral Rating	Mar. 08	MT
North American Morning Briefing : Stock Futures -2-	Mar. 08	DJ
UBS Upgrades Enhabit to Neutral From Sell, $9.50 Price Target	Mar. 07	MT
Transcript : Enhabit, Inc., 2023 Earnings Call, Mar 07, 2024	Mar. 07
North American Morning Briefing : Powell Still in -2-	Mar. 07	DJ
Enhabit, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 06	CI
Earnings Flash (EHAB) ENHABIT Reports Q4 EPS $0.06, vs. Street Est of $0.03	Mar. 06	MT
Jefferies Adjusts Price Target on Enhabit to $14 From $15, Maintains Buy Rating	Mar. 06	MT
North American Morning Briefing : Stock Futures -2-	Mar. 06	DJ
TD Cowen Starts Enhabit With Market Perform Rating	Dec. 12	MT
Transcript : Enhabit, Inc., Q3 2023 Earnings Call, Nov 08, 2023	Nov. 08
Enhabit, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07	CI
Enhabit, Inc. Enters Second Amendment to the Credit Agreement	Nov. 07	CI
Earnings Flash (EHAB) ENHABIT Reports Q3 EPS $0.03, vs. Street Est of $0.07	Nov. 07	MT
(EHAB) ENHABIT Expects Fiscal Year 2023 EPS Range $0.09 - $0.31	Nov. 07	MT
Enhabit, Inc. Revises Earnings Guidance for the Year 2023	Nov. 07	CI
AREX Capital Management Issues Letter to Board of Directors of Enhabit	23-10-05	CI
Enhabit Formally Launches Strategic Alternatives Review Process; Shares Rise After Hours	23-08-23	MT
Enhabit Begins Exploration of Strategic Alternatives	23-08-22	CI
Credit Suisse Adjusts Enhabit's Price Target to $12 From $15, Keeps Neutral Rating	23-08-11	MT
Transcript : Enhabit, Inc., Q2 2023 Earnings Call, Aug 10, 2023	23-08-10
Enhabit, Inc. Revises earnings Guidance Its Full-Year 2023	23-08-09	CI
Earnings Flash (EHAB) ENHABIT Reports Q2 EPS $0.04, vs. Street Est of $0.13	23-08-09	MT
(EHAB) ENHABIT Forecasts Fiscal Year 2023 EPS Range $0.28 - $0.46	23-08-09	MT
Enhabit, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI

Chart Enhabit, Inc.

Duration

Period

More charts

Company Profile

Enhabit, Inc. is a provider of home health and hospice services. The Companyâs segments include Home Health and Hospice. The Home Health segment provides a range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational and speech therapy, medical social work, and home health aide services. Its home health business benefits from a diversity of referral sources, with patients referred from acute care hospitals, inpatient rehabilitation facilities, surgery centers, assisted living facilities, and skilled nursing facilities, as well as community physicians. The Hospice segment provides hospice services for terminally ill patients and their families. Its Medicare-certified hospice operations provide hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and family member bereavement counseling. It operates over 110 hospice agencies and 255 home health agencies.

Sector

Healthcare Facilities & Services

Calendar

2024-05-07 - Q1 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Enhabit, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

9.99 USD

Average target price

10.93 USD

Spread / Average Target

+9.40%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Home Healthcare Services

	1st Jan change	Capi.
ENHABIT, INC.	-1.16%	501M
AMEDISYS, INC.	-3.07%	3.02B
BRIGHTSPRING HEALTH SERVICES, INC.	0.00%	1.89B
ADDUS HOMECARE CORPORATION	+4.15%	1.59B
THE PENNANT GROUP, INC.	+54.89%	637M
DOCGO INC.	-37.39%	358M
SAINT-CARE HOLDING CORPORATION	-11.94%	141M
KATO (HONG KONG) HOLDINGS LIMITED	+1.92%	70.36M

Home Healthcare Services